CN105250549A - Traditional Chinese medicine composition for relieving sequela of apoplexy - Google Patents
Traditional Chinese medicine composition for relieving sequela of apoplexy Download PDFInfo
- Publication number
- CN105250549A CN105250549A CN201510803364.8A CN201510803364A CN105250549A CN 105250549 A CN105250549 A CN 105250549A CN 201510803364 A CN201510803364 A CN 201510803364A CN 105250549 A CN105250549 A CN 105250549A
- Authority
- CN
- China
- Prior art keywords
- radix
- apoplexy
- sequela
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for relieving sequela of apoplexy, and belongs to the field of pharmacy. The composition is prepared from the following raw materials: raw astragalus membranaceus, radix rehmanniae praeparata, angelica sinensis, radix paeoniae rubra, ligusticum wallichii, peach kernels, safflower carthamus, periostracum cicada, earthworms, bombyx batryticatus, rhizoma acori graminei, scorpion, centipedes, salviae miltiorrhizae, cowherb seeds, tangerine piths and licorice root. The traditional Chinese medicine composition has the effects of promoting blood circulation to remove stasis and expelling wind to dredge collaterals on sequela of apoplexy from internal functions, and has a good curative effect on relieving sequela of apoplexy.
Description
Technical field
The present invention relates to the production field of medicine, particularly a kind of Chinese medicine composition alleviating apoplexy sequela.
Background technology
Apoplexy is commonly encountered diseases, the frequently-occurring disease of person in middle and old age, be a kind of with cerebral ischemic and heamorrhagic lesions symptom for Major Clinical internal medicine common disease.Although stroke patient is through active treatment, mostly still there is sequela, i.e. apoplexy sequela, upper and lower extremities paralysis in common side is unable, and munbness, facial hemiparalysis, sialorrhea, shallow complexion, stiff tongue language is stuttering.If not as good as early treatment, then spasm is stiff gradually for limbs, and the useless property of generation limbs is tetanic, contracture, causes cacomelia and afunction etc.Must cross the patient of apoplexy, also easily recur again, often recur once, increase the weight of once, so improve the prophylactic treatment level of apoplexy, sickness rate, the disability rate of reduction apoplexy, treatment and the conditioning of strengthening cerebral apoplexy sequela are the task of top priority.
At present, the treatment of doctor trained in Western medicine to cerebral apoplexy sequela adopts the Therapeutic Method such as oral administration and external daubing medicament more, though rapid-action, late result is unsatisfactory.And prolonged administration of drugs easily develops immunity to drugs, there is side effect in various degree to digestive tract and nervous system, also can cause damage in various degree to digestive tract, and expense is relatively high.
Summary of the invention
The present invention is in order to solve the problem in background technology, and provide a kind of medicine alleviating effective, gentle, the low cost of apoplexy sequela, it is by Radix Astragali, Radix Rehmanniae Preparata, Radix Angelicae Sinensis, Radix Paeoniae Rubra, Rhizoma Chuanxiong, Semen Persicae, Flos Carthami, Periostracum Cicadae, Pheretima, Bombyx Batryticatus, Rhizoma Acori Graminei, Scorpio, Scolopendra, Radix Salviae Miltiorrhizae, Semen Vaccariae, Vascular aurantii, Radix Glycyrrhizae etc. ten seven flavor medicine forms.
The technical scheme of the embodiment of the present invention is as follows:
Get following medical material by weight ratio and make Chinese medicine: Radix Astragali 45-55g, Radix Rehmanniae Preparata 10-20g, Radix Angelicae Sinensis 10-20g, Radix Paeoniae Rubra 10-20g, Rhizoma Chuanxiong 10-20g, Semen Persicae 8-12g, Flos Carthami 8-12g, Periostracum Cicadae 8-12g, Pheretima 28-32g, Bombyx Batryticatus 8-12g, Rhizoma Acori Graminei 8-12g, Scorpio 4-6g, Scolopendra 1-3 bar, Radix Salviae Miltiorrhizae 15-25g, Semen Vaccariae 10-20g, Vascular aurantii 8-12g, Radix Glycyrrhizae 8-12g.
Particularly, raw material of the present invention is made up of following raw material by weight ratio: Radix Astragali 50g, Radix Rehmanniae Preparata 15g, Radix Angelicae Sinensis 15g, Radix Paeoniae Rubra 15g, Rhizoma Chuanxiong 15g, Semen Persicae 10g, Flos Carthami 10g, Periostracum Cicadae 10g, Pheretima 30g, Bombyx Batryticatus 10g, Rhizoma Acori Graminei 10g, Scorpio 5g, Scolopendra 2, Radix Salviae Miltiorrhizae 20g, Semen Vaccariae 15g, Vascular aurantii 10g, Radix Glycyrrhizae 10g.
Manufacture method: after the Chinese medicine composition of alleviation apoplexy sequela of the present invention is added water, wherein amount of water is 150-300 times of the Chinese lavipeditum composition weight alleviating apoplexy sequela, 30-60 minute is decocted at 100 DEG C of high temperature, filter and remove residue takes concoction, the medicine juice decocted is poured into and adopts commercially available special foot bath, amount of liquid medicine is advisable with 1000 ~ 2000mL, proper temperature is regulated according to season and patient tolerance, fluid temperature is generally advisable with 40 DEG C ~ 45 DEG C, soak about 20min, 1 times/day, within 2 weeks, be 1 course for the treatment of, every day changed 1 time by medicinal liquid.
The present invention compared with prior art has the following advantages:
Medicine provided by the present invention is Chinese medicine, and Chinese medicine is based on draft, is accompanied by mineral drug and animal drugs, and often kind of medicine cures mainly from form, nature and flavor, Gui Jing, function has it unique.When applying, can because of people, apply in a flexible way because the different arbitrarily plus-minus such as disease, to reach the object of disease therapy; It can determine the time, the duration and degree of heating etc. of decoction at any time according to the position difference of the nature and flavor of medicine used, quality weight, medicine, can not cause overmedicate.Chinese crude drug, through simple Physical Processing, refines into different dosage forms and takes.These two kinds of approach seldom have chemical reaction, therefore effective ingredient not easily scatters and disappears, and side effect is little.Chinese medicinal material is taken at natural ore, plant mostly, except side effect own is little, cheap.Chinese medicine is with a long history, is the product of the long-term production practices of China working people and medical practice, its good effect, effects a radical cure the feature such as fast and has obtained the public and confirm.
Detailed description of the invention
Embodiment: get following medical material by weight ratio and make Chinese medicine: process Radix Astragali 50g, Radix Rehmanniae Preparata 15g, Radix Angelicae Sinensis 15g, Radix Paeoniae Rubra 15g, Rhizoma Chuanxiong 15g, Semen Persicae 10g, Flos Carthami 10g, Periostracum Cicadae 10g, Pheretima 30g, Bombyx Batryticatus 10g, Rhizoma Acori Graminei 10g, Scorpio 5g, Scolopendra 2, Radix Salviae Miltiorrhizae 20g, Semen Vaccariae 15g, Vascular aurantii 10g, Radix Glycyrrhizae 10g, after the Chinese medicine composition of alleviation apoplexy sequela of the present invention is added water, wherein amount of water is 150-300 times of the Chinese lavipeditum composition weight alleviating apoplexy sequela, 30-60 minute is decocted at 100 DEG C of high temperature, filter and remove residue takes concoction, the medicine juice decocted is poured into and adopts commercially available special foot bath, amount of liquid medicine is advisable with 1000 ~ 2000mL, proper temperature is regulated according to season and patient tolerance, fluid temperature is generally advisable with 40 DEG C ~ 45 DEG C, soak about 20min, 1 times/day, it within 2 weeks, is 1 course for the treatment of, every day changed 1 time by medicinal liquid.
One, clinical observation
1, clinical data: this group 110 example, man 63 example, female 47 example; 38 ~ 74 years old age, 61 years old mean age; Course of disease elder 8 years, short person 3 months, average course of disease 11 months.All patients is all diagnosed as apoplexy sequela through hospitalization in conjunction with symptom, sign.Symptom and sign: be single lower limb limitation of activity, muscular strength such as to go down at the symptom.
2, Therapeutic Method: after the Chinese lavipeditum composition of alleviation apoplexy sequela of the present invention is added water, wherein amount of water is 150-300 times of the Chinese lavipeditum composition weight alleviating apoplexy sequela, 30-60 minute is decocted at 100 DEG C of high temperature, filter and remove residue takes concoction, the medicine juice decocted is poured into and adopts commercially available special foot bath, amount of liquid medicine is advisable with 1000 ~ 2000mL, proper temperature is regulated according to season and patient tolerance, fluid temperature is generally advisable with 40 DEG C ~ 45 DEG C, soak about 20min, 1 times/day, within 2 weeks, be 1 course for the treatment of, every day changed 1 time by medicinal liquid.
3, criterion of therapeutical effect:
Basic healing: paralyzed limbs motor function is recovered substantially, life can be taken care of oneself, facial hemiparalysis, dysphonia transference cure;
Effective: paralyzed limbs function is clearly better, life is taken care of oneself substantially;
Invalid: before and after treatment, symptom is without change.
4, therapeutic outcome: basic healing 78 example, effective 28 examples, invalid 4 examples, total effective rate is 96.3%.In sum, the present invention is used for the treatment of the Chinese medicine composition of cerebral apoplexy sequela, and through clinical trial, show that it can effectively suppress cerebral apoplexy sequela PD, improve patients symptomatic, sign, determined curative effect, cure rate is high, and without obvious toxic-side effects.
Two, model case
Case 1: grandson so-and-so, female, 68 years old.Patient previously has hypertension medical history 8 years, takes depressor always, suddenly goes into a coma the year before because of excited, flush, rapid breathing, through rescuing stable disease, but it is serious to leave over left upper extremity flexing, the facial muscular paralysis in left side is unable simultaneously, has a strong impact on the daily life of patient.Once take a lot of medicine, have no obvious curative effects, because Long-term taking medicine causes serious gastritis.After using 2 courses for the treatment of of medicament pedicuring of the present invention afterwards, it is day by day normal that left limb stretches act, 2 courses for the treatment of of after treatment, and left side face muscular paralysis symptom disappears substantially, existing walk freely, life can take care of oneself.Follow up a case by regular visits to 3 months, have no recurrence.
Case 2: Sui so-and-so, man, 61 years old.Patient in a year and a half prolapse send out slurred speech, distortion of commissure, unstable hospitalization of walking, is diagnosed as cerebral thrombosis through CT, within 22 days, leave hospital in hospital, myodynamia 3 grades on the right side of when leaving hospital, after take a lot of in, western medicine, the state of an illness has no obvious improvement, medicine of the present invention is brought into use to carry out pedicure after being introduced, after controlling three courses for the treatment of of medicine, above-mentioned symptom alleviates, can independent ambulation and carry out simple spoken dialog.Two courses for the treatment of of continual cure, above symptom disappears substantially, follows up a case by regular visits to and does not recur half a year.
Claims (2)
1. alleviate a Chinese medicine composition for apoplexy sequela, it is characterized in that, be made up of following raw materials by weight portion: Radix Astragali 45-55g, Radix Rehmanniae Preparata 10-20g, Radix Angelicae Sinensis 10-20g, Radix Paeoniae Rubra 10-20g, Rhizoma Chuanxiong 10-20g, Semen Persicae 8-12g, Flos Carthami 8-12g, Periostracum Cicadae 8-12g, Pheretima 28-32g, Bombyx Batryticatus 8-12g, Rhizoma Acori Graminei 8-12g, Scorpio 4-6g, Scolopendra 1-3 bar, Radix Salviae Miltiorrhizae 15-25g, Semen Vaccariae 10-20g, Vascular aurantii 8-12g, Radix Glycyrrhizae 8-12g.
2. a kind of Chinese medicine composition alleviating apoplexy sequela according to claim 1, is characterized in that, be made up of following raw materials by weight portion: Radix Astragali 50g, Radix Rehmanniae Preparata 15g, Radix Angelicae Sinensis 15g, Radix Paeoniae Rubra 15g, Rhizoma Chuanxiong 15g, Semen Persicae 10g, Flos Carthami 10g, Periostracum Cicadae 10g, Pheretima 30g, Bombyx Batryticatus 10g, Rhizoma Acori Graminei 10g, Scorpio 5g, Scolopendra 2, Radix Salviae Miltiorrhizae 20g, Semen Vaccariae 15g, Vascular aurantii 10g, Radix Glycyrrhizae 10g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510803364.8A CN105250549A (en) | 2015-11-20 | 2015-11-20 | Traditional Chinese medicine composition for relieving sequela of apoplexy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510803364.8A CN105250549A (en) | 2015-11-20 | 2015-11-20 | Traditional Chinese medicine composition for relieving sequela of apoplexy |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105250549A true CN105250549A (en) | 2016-01-20 |
Family
ID=55090678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510803364.8A Pending CN105250549A (en) | 2015-11-20 | 2015-11-20 | Traditional Chinese medicine composition for relieving sequela of apoplexy |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105250549A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105687798A (en) * | 2016-03-22 | 2016-06-22 | 山东明人福瑞达卫生材料有限公司 | External traditional Chinese medicinal preparation for treating stroke and preparation method of external traditional Chinese medicinal preparation |
FR3081326A1 (en) * | 2018-05-24 | 2019-11-29 | Xun Huang | PHARMACEUTICAL COMPOSITION FOR HAT FOR MEDICAL TREATMENT AND HEALTH CARE |
-
2015
- 2015-11-20 CN CN201510803364.8A patent/CN105250549A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105687798A (en) * | 2016-03-22 | 2016-06-22 | 山东明人福瑞达卫生材料有限公司 | External traditional Chinese medicinal preparation for treating stroke and preparation method of external traditional Chinese medicinal preparation |
FR3081326A1 (en) * | 2018-05-24 | 2019-11-29 | Xun Huang | PHARMACEUTICAL COMPOSITION FOR HAT FOR MEDICAL TREATMENT AND HEALTH CARE |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101757569A (en) | Traditional Chinese medicine composition for treating cerebral thrombosis and cerebral infarction and preparation method thereof | |
CN101129620A (en) | Traditional Chinese medicine for treating nasosinusitis headache | |
CN101164588A (en) | Traditional Chinese medicine for treating yin deficiency and fire excess type palpitation | |
CN101129862A (en) | Traditional Chinese medicine for treating acute renal glomerulus nephritis | |
CN104127699A (en) | Vitality-tonifying health-preserving preparation and preparation method thereof | |
CN101129496A (en) | Traditional Chinese medicine for treating obstinate headache | |
CN101152325A (en) | Traditional Chinese medicine for treating multiple hemorrhoid gall | |
CN104873898A (en) | Preparation, namely blood conducting powder containing kudzuvine root and safflower, for treating hemiplegia | |
CN101152354A (en) | Traditional Chinese medicine for treating acute dacryocystitis | |
CN101152252A (en) | Traditional Chinese medicine for treating chronic rhinitis | |
CN102512552B (en) | Traditional Chinese medicine composition for treating exogenous fever | |
CN105250549A (en) | Traditional Chinese medicine composition for relieving sequela of apoplexy | |
CN101152299A (en) | Traditional Chinese medicine for treating goiter and tumor | |
CN101152494A (en) | Traditional Chinese medicine for treating acute appendicitis | |
CN101167890A (en) | Traditional Chinese medicine for treating superficial punctuate keratitis | |
CN101138613A (en) | Chinese traditional medicine for treating acute bronchitis of children | |
CN105456745A (en) | Medicine composition for treating sequela of apoplexy | |
CN103285300A (en) | Medicinal composition for treating stress incontinence | |
CN107837319A (en) | A kind of Chinese medicine composition for alleviating apoplexy sequelae | |
CN101129554A (en) | Traditional Chinese medicine for treating sick headache | |
CN103393961B (en) | Traditional Chinese medicine for treating cervical spondylosis and preparation method thereof | |
CN101129694A (en) | Traditional Chinese medicine for treating muscular contraction headache | |
CN101966304A (en) | Medicament for freeing network vessels and activating blood and preparation method thereof | |
CN101953999B (en) | Medicinal composition for treating paralysis and preparation method thereof | |
CN101152435A (en) | Traditional Chinese medicine for treating urgent sinusitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160120 |
|
WD01 | Invention patent application deemed withdrawn after publication |